Skip to main
INKT
INKT logo

MiNK Therapeutics (INKT)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy MiNK Therapeutics (INKT) Stock

About MiNK Therapeutics (INKT)

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.
Market cap$29.44M
Today's volume1.26K
Revenue (TTM)
Avg. daily volume7.92K
EBITDA (TTM)-$9.14M
Open$7.36
Price / earnings ratio-2.95x
Today's range$7.36 - $7.36
Debt / equity
52 week range$4.56 - $13.79
5 year debt / equity-21.3x
Beta (LTM)0.41x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio0.3x
Ex-dividend date
Next earningsAug 12, 2025
Dividend payable date

MiNK Therapeutics Stock Rating

What analysts recommend for INKT stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for INKT stock is $29.45M

The current P/E ratio for INKT stock is -2.95

The 52-week high for INKT stock is $13.79. The current INKT stock price $undefined is 100.00% below its 52-week high

The 52-week low for INKT stock is $4.56. The current INKT stock price $undefined has increased 100.00% from its 52-week low

No, the INKT stock does not pay dividends to its shareholders

The target price for INKT stock is $13 based on the average of what a group of analyst think INKT stock could be worth at a future date. This is not a prediction by Public.com

How to buy INKT stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in INKT stock

    Navigate to the Explore page. Then, type INKT into the search bar. When you see INKT stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased INKT stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

MiNK Therapeutics Stock Earnings

The value each INKT share was expected to gain vs. the value that each INKT share actually gained.

MiNK Therapeutics (INKT) reported Q1 2025 earnings per share (EPS) of -$0.70, missing estimates of -$0.61 by 14.75%. In the same quarter last year, MiNK Therapeutics's earnings per share (EPS) was -$0.11. MiNK Therapeutics is expected to release next earnings on 08/12/2025, with an earnings per share (EPS) estimate of -$0.46.

Buy MiNK Therapeutics (INKT) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.